Abstract
The attributes of the zebrafish (Danio rerio) make it an excellent model system for the development and discovery of new drugs. A robust behavioral assay is described that has been used successfully in studies of nicotine biology. The movement response of a group of larval zebrafish is measured over a 5-min period following application of nicotine. Pretreatment of larvae is employed to identify chemical compounds that reduce locomotor responses to acute nicotine. Activity plots provide an assessment of the biological activity and specificity of neuroactive chemical compounds in intact organisms. The experimental setup can be established in a research or teaching laboratory. The described behavioral assay can be used in pharmacological studies for the characterization of new chemical compounds and is a powerful tool for the discovery of behavioral zebrafish mutants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kenakin T (2003) Predicting therapeutic value in the lead optimization phase of drug discovery. Nat Rev Drug Discov 2:429–438
Tecott LH, Nestler EJ (2004) Neurobehavioral assessment in the information age. Nat Neurosci 7:462–466
Kenakin TP (2009) Cellular assays as portals to seven-transmembrane receptor-based drug discovery. Nat Rev Drug Discov 8:617–626
Baldessari D, Mione M (2008) How to create the vascular tree? (Latest) help from the zebrafish. Pharmacol Ther 118:206–230
Berghmans S, Hunt J, Roach A, Goldsmith P (2007) Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res 75:18–28
Buckley CE, Marguerie A, Roach AG, Goldsmith P, Fleming A, Alderton WK, Franklin RJM (2010) Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology 59:149–159
Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, Elkhayat SI, Bartels BK, Tien AK, Tien DH, Mohnot S, Beeson E, Glasgow E, Amri H, Zukowska Z, Kalueff AV (2009) Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 205:38–44
Kitambi SS, McCulloch KJ, Peterson RT, Malicki JJ (2009) Small molecule screen for compounds that affect vascular development in the zebrafish retina. Mech Dev 126:464–477
Love DR, Pichler FB, Dodd A, Copp BR, Greenwood DR (2004) Technology for high-throughput screens: the present and future using zebrafish. Curr Opin Biotechnol 15:564–571
MacRae CA, Peterson RT (2003) Zebrafish-based small molecule discovery. Chem Biol 10:901–908
McAleer MF, Davidson C, Davidson WR, Yentzer B, Farber SA, Rodeck U, Dicker AP (2005) Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers. Int J Radiat Oncol Biol Phys 61:10–13
McGrath P, Li C-Q (2008) Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 13:394–401
McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, Rubinstein AL (2005) Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Mol Brain Res 141:128–137
Meeker ND, Trede NS (2008) Immunology and zebrafish: spawning new models of human disease. Dev Comp Immunol 32:745–757
Murphey RD, Zon LI (2006) Small molecule screening in the zebrafish. Methods 39:255–261
Nguyen CT, Lu Q, Wang Y, Chen J-N (2008) Zebrafish as a model for cardiovascular development and disease. Drug Discov Today Dis Models 5:135–140
Peterson RT (2004) Discovery of therapeutic targets by phenotype-based zebrafish screens. Drug Discov Today Technol 1:49–54
Peterson RT, Fishman MC (2004) Discovery and use of small molecules for probing biological processes in zebrafish. Methods Cell Biol 76:569–591
Redfern WS, Waldron G, Winter MJ, Butler P, Holbrook M, Wallis R, Valentin J-P (2008) Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? J Pharmacol Toxicol Methods 58:110–117
Sumanas S, Lin S (2004) Zebrafish as a model system for drug target screening and validation. Drug Discov Today Targets 3:89–96
Winter MJ, Redfern W, Hayfield A, Owen S, Valentin JP, Hutchinson T (2008) Zebrafish embryo-larval locomotion as a frontloaded screen for assessing seizure liability during early drug discovery. J Pharmacol Toxicol Methods 58:169
Eddins D, Petro A, Williams P, Cerutti DT, Levin ED (2009) Nicotine effects on learning in zebrafish: the role of dopaminergic systems. Psychopharmacology (Berl) 202:103–109
Bencan Z, Levin ED (2008) The role of alpha7 and alpha4 beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiol Behav 95:408–412
Levin ED, Bencan Z, Cerutti DT (2007) Anxiolytic effects of nicotine in zebrafish. Physiol Behav 90:54–58
Levin ED, Chen E (2004) Nicotinic involvement in memory function in zebrafish. Neurotoxicol Teratol 26:731–735
Klee EW, Ebbert JO, Schneider H, Hurt RD, Ekker SC (2011) Zebrafish for the study of the biological effects of nicotine. Nicotine Tob Res 13:301–312
Petzold AM, Balciunas D, Sivasubbu S, Clark KJ, Bedell VM, Westcot SE, Myers SR, Moulder GL, Thomas MJ, Ekker SC (2009) Nicotine response genetics in the zebrafish. Proc Natl Acad Sci U S A 106:18662–18667
Drapeau P, Saint-Amant L, Buss RR, Chong M, McDearmid JR, Brustein E (2002) Development of the locomotor network in zebrafish. Prog Neurobiol 68:85–111
Buss RR, Drapeau P (2001) Synaptic drive to motoneurons during fictive swimming in the developing zebrafish. J Neurophysiol 86:197–210
Budick SA, O’Malley DM (2000) Locomotor repertoire of the larval zebrafish: swimming, turning and prey capture. J Exp Biol 203:2565–2579
Thirumalai V, Cline HT (2008) Endogenous dopamine suppresses initiation of swimming in prefeeding zebrafish larvae. J Neurophysiol 100:1635–1648
Lawrence C (2007) The husbandry of zebrafish (Danio rerio): a review. Aquaculture 269:1–20
MacPhail RC, Brooks J, Hunter DL, Padnos B, Irons TD, Padilla S (2009) Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 30:52–58
Sallinen V, Sundvik M, Reenila I, Peitsaro N, Khrustalyov D, Anichtchik O, Toleikyte G, Kaslin J, Panula P (2009) Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 109:403–415
Emran F, Rihel J, Dowling JE (2008) A behavioral assay to measure responsiveness of zebrafish to changes in light intensities. J Vis Exp 3(20):923. doi:10.3791/923
Budick SB, O’Malley DM (2000) Minimal behavioural deficits are observed after laser-ablation of the nMLF in larval zebrafish. Am Zool 40:959
Borla MA, Palecek B, Budick S, O’Malley DM (2002) Prey capture by larval zebrafish: evidence for fine axial motor control. Brain Behav Evol 60:207–229
McLean DL, Fetcho JR (2011) Movement, technology and discovery in the zebrafish. Curr Opin Neurobiol 21:110–115
Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, Jang S, Haggarty SJ, Kokel D, Rubin LL, Peterson RT, Schier AF (2010) Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327:348–351
Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, Macrae CA, Shoichet B, Peterson RT (2010) Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 6:231–237
Pardo-Martin C, Chang TY, Koo BK, Gilleland CL, Wasserman SC, Yanik MF (2010) High-throughput in vivo vertebrate screening. Nat Methods 7:634–636
Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203:253–310
Brand M, Granato M, Nüsslein-Volhard C (2002) Keeping and raising zebrafish. In: Nüsslein-Volhard C, Dahm R (eds) Zebrafish, 1st edn. Oxford University Press, New York, NY, pp 7–37
Burgess HA, Granato M (2007) Modulation of locomotor activity in larval zebrafish during light adaptation. J Exp Biol 210:2526–2539
Murphey RD, Stern HM, Straub CT, Zon LI (2006) A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 68:213–219
Usenko CY, Harper SL, Tanguay RL (2007) In vivo evaluation of carbon fullerene toxicity using embryonic zebrafish. Carbon N Y 45:1891–1898
Clark KJ, Boczek NJ, Ekker SC (2011) Stressing zebrafish for behavioral genetics. Rev Neurosci 22:49–62
Sackerman J, Donegan JJ, Cunningham CS, Nguyen NN, Lawless K, Long A, Benno RH, Gould GG (2010) Zebrafish behavior in novel environments: effects of acute exposure to anxiolytic compounds and choice of Danio rerio line. Int J Comp Psychol 23:43–61
Hicks C, Sorocco D, Levin M (2006) Automated analysis of behavior: a computer-controlled system for drug screening and the investigation of learning. J Neurobiol 66:977–990
Branson K, Robie AA, Bender J, Perona P, Dickinson MH (2009) High-throughput ethomics in large groups of Drosophila. Nat Methods 6:451–457
Dews PB (1955) Studies on behavior. II. The effects of pentobarbital, methamphetamine and scopolamine on performances in pigeons involving discriminations. J Pharmacol Exp Ther 115:380–389
Dews PB (1955) Studies on behavior. I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward. J Pharmacol Exp Ther 113:393–401
Clark KJ, Balciunas D, Pogoda HM, Ding Y, Westcot SE, Bedell VM, Greenwood TM, Urban MD, Skuster KJ, Petzold AM, Ni J, Nielsen AL, Patowary A, Scaria V, Sivasubbu S, Xu X, Hammerschmidt M, Ekker SC (2011) In vivo protein trapping produces a functional expression codex of the vertebrate proteome. Nat Methods 8:506–512
Ekker SC (2000) Morphants: a new systematic vertebrate functional genomics approach. Yeast 17:302–306
Bill BR, Petzold AM, Clark KJ, Schimmenti LA, Ekker SC (2009) A primer for morpholino use in zebrafish. Zebrafish 6:69–77
Nasevicius A, Ekker SC (2000) Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 26:216–220
Moens CB, Donn TM, Wolf-Saxon ER, Ma TP (2008) Reverse genetics in zebrafish by TILLING. Brief Funct Genomic Proteomic 7:454–459
Wang D, Jao LE, Zheng N, Dolan K, Ivey J, Zonies S, Wu X, Wu K, Yang H, Meng Q, Zhu Z, Zhang B, Lin S, Burgess SM (2007) Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions. Proc Natl Acad Sci U S A 104:12428–12433
Acknowledgments
Support for this project was provided by DePauw University, NIH DA014546 to SCE, and Mayo Foundation. We thank the team of the Mayo Clinic Zebrafish facility and members of the Ekker-lab for their help and suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Schneider, H. et al. (2012). Zebrafish and Drug Development: A Behavioral Assay System for Probing Nicotine Function in Larval Zebrafish. In: Kalueff, A., Stewart, A. (eds) Zebrafish Protocols for Neurobehavioral Research. Neuromethods, vol 66. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-597-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-61779-597-8_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-596-1
Online ISBN: 978-1-61779-597-8
eBook Packages: Springer Protocols